Norden Group’s Gilead Sciences GILD Stock Holding History

Norden Group’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.22M	Sell	30,297 -750	-2%	-$105K	0.41%	52
2025 Q4	$3.81M	Buy	31,047 +438	+1%	+$53.2K	0.37%	54
2025 Q3	$3.4M	Sell	30,609 -43,162	-59%	-$4.91M	0.35%	57
2025 Q2	$8.18M	Buy	73,771 +46,725	+173%	+$4.97M	0.89%	18
2025 Q1	$3.03M	Buy	27,046 +942	+4%	+$97.2K	0.35%	59
2024 Q4	$2.41M	Buy	26,104 +345	+1%	+$31.1K	0.27%	82
2024 Q3	$2.16M	Buy	25,759 +15,653	+155%	+$1.19M	0.25%	88
2024 Q2	$693K	Sell	10,106 -1,973	-16%	-$132K	0.14%	160
2024 Q1	$885K	Sell	12,079 -15,084	-56%	-$1.16M	0.18%	128
2023 Q4	$2.2M	Buy	27,163 +19,177	+240%	+$1.49M	0.38%	26
2023 Q3	$598K	Buy	+7,986	New	+$614K	0.2%	118

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Norden Group's GILD Position: Q1 2026 in Review

Norden Group reduced its Gilead Sciences (GILD) stake by 2.4% in Q1 2026, selling an estimated $105K and leaving 30,297 shares worth $4.22M. The position accounts for 0.41% of the portfolio, ranked #52.

Norden Group first reported a position in GILD in Q3 2023 and has held it in 11 quarters since. The position peaked at $8.18M in Q2 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Norden Group held 30,297 shares of Gilead Sciences worth $4.22M as of Q1 2026.
Norden Group sold 750 Gilead Sciences shares in Q1 2026, an estimated $105K.
Gilead Sciences made up 0.41% of Norden Group's portfolio in Q1 2026, its #52 holding.
Norden Group first reported a position in Gilead Sciences in Q3 2023 and has held it in 11 quarters since.
Norden Group's Gilead Sciences position peaked at $8.18M in Q2 2025.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Norden Group's 13F filing for Q1 2026, filed 15 Apr 2026.